Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
about
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSRegulation of glycogen synthase kinase-3 during bipolar mania treatmentTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderReview of pharmacological treatment in mood disorders and future directions for drug development.Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugsLong-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of miceGenetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.Is glycogen synthase kinase-3 a central modulator in mood regulation?Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.Targeting protein kinases in central nervous system disordersSignaling pathways underlying the antidepressant-like effect of inosine in miceA new avenue for lithium: intervention in traumatic brain injury.Role of the adipose PPARγ-adiponectin axis in susceptibility to stress and depression/anxiety-related behaviors.Role of the axonal initial segment in psychiatric disorders: function, dysfunction, and interventionWnt2 expression and signaling is increased by different classes of antidepressant treatments.Hyperforin promotes mitochondrial function and development of oligodendrocytes.Pioglitazone could induce remission in major depression: a meta-analysisGSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersTime-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine.Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation.Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteins.Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.The wnt pathway in mood disordersGlycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo.Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin NeurotransmissionNew drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.PPARγ and stress: implications for aging.Functional significance of glycogen synthase kinase-3 regulation by serotonin.FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications.Small Molecule Inhibitors of Regulator of G Protein Signalling (RGS) ProteinsEvidence of the involvement of K+ channels and PPARgamma receptors in the antidepressant-like activity of diphenyl diselenide in mice.Role of exercise on molecular mechanisms in the regulation of antidepressant effects.Therapeutic strategies for treatment of inflammation-related depression.Ketamine up-regulates a cluster of intronic miRNAs within the serotonin receptor 2C gene by inhibiting glycogen synthase kinase-3.On the effect of minocycline on the depressive-like behavior of mice repeatedly exposed to malathion: interaction between nitric oxide and cholinergic system.Minocycline Attenuates Depressive-Like Behaviour Induced by Rat Model of Testicular Torsion: Involvement of Nitric Oxide Pathway.
P2860
Q21129334-4EFD98D2-4831-49F1-A5A7-BC6090EF54D0Q24594534-BA19F3BB-EDCA-41D9-942F-26F06E21BCB7Q24626017-C53A0AC0-697C-4E88-82C3-A392B7B89F48Q26853509-08220B2A-770C-49B1-807E-6841556FA8E0Q28305100-CBA117CA-3DCE-4F48-8DC3-855F07498AAEQ28485938-8057FF20-E422-4ED4-AA9B-32D72C67281DQ30408186-96A82089-CF20-4DBB-BF33-FFC0579A9E05Q30475816-F0BD8F33-8C99-4A56-AE53-A3EE63CFEB5AQ30495108-3176C2C1-D0A3-444B-8E36-2A3C4EA73F78Q33671660-708F0DE9-1731-4D4F-B81B-AB71FCCB5695Q33689441-509F0E69-4F55-40D7-8A8C-9E2ED4CE0CE7Q33777980-C6F29507-BBBD-433F-9F08-10AB96E697AFQ33790412-269DA1D1-D0E9-478A-90E4-65280B9A3DB4Q34071914-94CE03CE-987F-4107-AEF9-179F991C4F36Q34088354-3D1FDC3E-4513-42F6-8CB5-514418B2D263Q34208604-D2CF40AF-4917-4554-90AB-2B41626032B4Q34548227-0B4AF791-6ACC-48F4-9DF9-B39174C45E80Q35154467-42A7329E-1119-42DE-8E68-A960B2A3655BQ35197096-74F94AC7-31E3-4D7B-88B9-9DA20EDD79B5Q35353085-9CE98A29-9B2F-4B09-B0E4-714864FF955EQ35356604-A999C2E0-55B6-449C-846E-4D48B0F0FEA1Q35557270-E2A545EF-0C5E-4575-8CC2-8943C9CFCA52Q35754079-F67E42BC-19F6-4C07-810B-C6CDE49C80C9Q35908493-E945D2B4-3990-48FC-8EDA-BCE64C6FC78CQ36100305-7B96766C-E5F4-47E2-8029-CC6F3B136E94Q36310513-C913C209-6611-4288-9615-9B4C9D756731Q36415259-5571B004-F4A9-472E-BECC-E0041223F5F2Q37783637-074E4932-C066-4F3F-BEA9-509BD9A329D0Q37949586-F6304588-9286-40F6-B298-7FAC424FAF1EQ37978196-87216677-0955-40FD-9ABE-D6890E1DFA5BQ38041907-3CF6EB48-F01B-4A85-9125-D246EC0E2C21Q38887848-5D81550A-422D-4D2A-B056-2B1166FD518BQ38890067-08033895-AF2E-429C-8703-8F32A8EE1807Q41470342-C09DB630-E920-4B06-A584-BF3CB864D22EQ42925014-5D0AE50D-DE1F-4508-B633-A6D164488B3FQ47657495-B461296C-A627-42DA-9FE3-485E968CC0B7Q47785792-7E134815-3AE7-49B5-9AFB-E64FBD492CA5Q48039552-2E0A23F5-A24F-42CC-A956-4EE5D7A2F2D6Q48070234-7F9ECADE-1796-487C-B0A6-1C2B30BF61F8Q48074612-BA481AE6-77AE-4A1B-9E1A-54EE5996B628
P2860
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
@en
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
@nl
type
label
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
@en
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
@nl
prefLabel
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
@en
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
@nl
P2093
P50
P1476
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
@en
P2093
Ana Martinez
Angelo O Rosa
Ester Martín-Aparicio
Maria Luisa Navarro-Rico
Ricardo W Binfaré
Susana Morales
P304
P356
10.1016/J.PNPBP.2008.05.020
P577
2008-06-25T00:00:00Z